DoW Bone Marrow Failure, Investigator-Initiated Research Award

Key facts

Copied from the official Grants.gov record. Last verified October 29, 2026.

Program name

DoW Bone Marrow Failure, Investigator-Initiated Research Award

Issuing agency

Defense Health Agency Contracting Activity - DHACA (Department of Defense)

Opportunity number

HT942526BMFRPIIRA

Funding type

Grant

Funding purpose

Science and Technology and other Research and Development

Status

Open (posted)

Application deadline

Closes November 4, 2026(5 days left)

Published award range

Not published by the agency

Estimated total program funding

$1,250,000

Expected number of awards

1

Cost sharing or match required

No

Eligible applicants (official categories)

• Unrestricted (open to any type of entity, subject to any clarification in Additional Information on Eligibility)

Relevant to

Businesses and NonprofitsHow we determined this: Grants.gov lists eligibility as Unrestricted.

Geographic restrictions

None stated in structured data (federal opportunities are often nationwide). Check the eligibility details and full announcement for any limits.

Assistance Listing (CFDA)

12.420

Official source

View on Grants.gov ↗

Application URL

www.grants.gov/search-results-detail/362855 ↗Apply through Grants.gov (Workspace) using the application package on the official listing, unless the full announcement names a different submission system.

Source identifier

Grants.gov opportunity ID 362855 · Funding opportunity number HT942526BMFRPIIRA

Posted

June 17, 2026 · Source last updated June 23, 2026

Last verified

October 29, 2026 (against Grants.gov)

Data completeness

83% of key fields published by the sourceNot published: published funding range, eligibility criteria text.

Record confidence

highVerified against the official source; key fields present; no open issues.

Description (from the official listing)

Summary: Supports studies that further develop mature ideas, expand upon key discoveries, and have the potential to make significant advances in bone marrow (BMF) failure research and/or patient care. Investigator-Initiated Research Award (IIRA) applications may involve translational and clinical research including studies in preclinical models, research with human data and/or anatomical substances, and research with human subjects, as well as correlative studies associated with a clinical trial(s); however, this award mechanism does not support clinical trials. IIRA applications may also support Investigational New Drug (IND)-enabling efforts such as lead compound characterization, and assessments of formulation and stability, absorption, distribution, metabolism and excretion, dose/response and toxicology.Distinctive Features:This funding mechanism allows for a partnering Principal Investigator (PI). Only the initiating PI will submit a pre-application, but both PIs will need to submit full applications. The partnering PI application is an abbreviated package specific to their distinct portion of the research project. Be advised, all associated applications for a research project may be withdrawn if the initiating or partnering application is rejected or administratively withdrawn.This award mechanism requires preliminary data relevant to the proposed project. Applications can support clinical research studies; however, this mechanism does not allow clinical trials.

Agency contact

eBRAP Help Desk Phone: 301-682-5507 Email: help@eBRAP.org
help@eBRAP.org